Ciemniewski Z, Myszor J, Giec L
I Klinika Kardiologii Instytutu Kardiologii Slaskiej Akademii Medycznej.
Pol Arch Med Wewn. 1995 Jan;93(1):48-57.
The aim of the study has to be find, on basis of long term follow-up, an independent factors determining of pacemaker implantation in patients with intrinsic and extrinsic form of sick sinus syndrome. The second point was to find an independent risk factors of stroke and another serious complication in this group of patients (specially in paced group). The study group consisted 169 pts with sick sinus syndrome (in all pts abnormal electrophysiological tests--transoesophageal atrial stimulation). The form of sinus node dysfunction (extrinsic or intrinsic) was determined on basis of electrophysiological study after pharmacological denervation of the heart (propranolol and atropine i.v. in doses 0.2 and 0.04 mg/kg body weight respectively). The statistical analysis was performed on all pts (97 men and 72 women 48 +/- 16 yrs old) using Cox's model of proportional hazardous analysing. The follow-up period ranging from 14 to 84 months (mean 49.9 +/- 19). Pacemaker was implanted in 88 pts during observation period. Stroke signs were found in 7 pts including 6 pts after pacemaker implantation. There was 13 death (7 sudden or primary neurological death).
本研究的目的是基于长期随访,找出决定患有内在型和外在型病态窦房结综合征患者植入起搏器的独立因素。第二点是找出该组患者(特别是起搏组)中风和其他严重并发症的独立危险因素。研究组由169例病态窦房结综合征患者组成(所有患者均有异常电生理检查——经食管心房刺激)。根据心脏药物去神经支配(分别静脉注射0.2和0.04mg/kg体重的普萘洛尔和阿托品)后的电生理研究确定窦房结功能障碍的类型(外在型或内在型)。使用Cox比例风险分析模型对所有患者(97名男性和72名女性,年龄48±16岁)进行统计分析。随访期为14至84个月(平均49.9±19个月)。在观察期内,88例患者植入了起搏器。7例患者出现中风迹象,其中6例在植入起搏器后。有13例死亡(7例猝死或原发性神经死亡)。
1)植入起搏器的独立因素是晕厥、年龄和持续性心动过缓;2)窦房结功能障碍的类型不是这一决定的独立因素;3)年龄较大、起搏器植入后持续性晕厥以及经食管心电图记录的室房情况是VVI刺激患者中风的独立危险因素;4)尽管植入了起搏器(VVI模式),许多患者仍有晕厥前或晕厥发作,但该组患者的生活舒适度比植入前要好得多。